English | Español
Patient Daily | Apr 24, 2023

Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement
Patient Daily | Apr 24, 2023

Horizon Therapeutics plc Announces FDA Approval of an Update to the Indication Language for TEPEZZA® (teprotumumab-trbw) to Specify its Use in Thyroid Eye Disease (TED) Patients Regardless of Disease Activity or Duration
Patient Daily | Apr 24, 2023

Horizon Therapeutics plc to Release First-Quarter 2023 Financial Results on May 3, 2023
Patient Daily | Apr 24, 2023

Axtria And HealthVerity Announce Strategic Partnership To Enable Next-Gen Real-World Data, Analytics, And Campaign Optimization Solutions For Life Sciences Organizations
Patient Daily | Apr 24, 2023

Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting
Patient Daily | Apr 24, 2023

Jeune Aesthetics Announces Dosing of First Subject in Phase 1, Cohort 3 Study of KB301 for the Improvement of Lateral Canthal Lines at Rest
Patient Daily | Apr 24, 2023

Kaia Health Named As Top Digital Therapeutics Company by AVIA Marketplace
Patient Daily | Apr 21, 2023

The Importance of Cryopreservation in Regenerative Medicine

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’